Skip to content
← Survival collections

ARCHIVED POPULATION DATA

Pancreas

Archived November 2024 SEER release. This is relative survival from diagnosis for the published population, not an individual prediction or a treatment-effect estimate.

Relative survival across follow-up

0%25%50%75%100%0246810Years since diagnosis

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Exact archived source values · CI = confidence interval
YearRelative survival (%)95% CI lower95% CI upperStandard errorCases
0100Not publishedNot publishedNot published290003
132.994732.819633.16980.0894290003
218.560618.412618.7090.0756290003
313.619513.485213.75440.0687290003
411.427211.29911.55610.0656290003
510.212310.086610.33880.0644290003
69.43199.30689.55810.0641290003
78.84468.71888.97150.0645290003
88.39518.26768.52370.0653290003
98.03957.90948.17080.0667290003
107.68897.55537.82390.0685290003
Permanent reference to this archived population →
Source definitions, footnotes and provenance
age and race caveat
Published age/race categories can overlap. They are selectable strata, not partitions to add together.
cohort count definition
Source Number of Cases, repeated by follow-up row; not people remaining at risk.
dimensions
Age at Diagnosis
  1. Ages 15-39
  2. Ages 40-64
  3. Ages 50-64
  4. Ages 65+
  5. Ages 65-74
  6. Ages 75+
  7. Ages < 15
  8. Ages < 20
  9. Ages < 50
  10. All Ages
Race/Ethnicity
  1. All Races / Ethnicities
  2. Black (includes Hispanic)
  3. Hispanic (any race)
  4. Non-Hispanic American Indian / Alaska Native
  5. Non-Hispanic Asian / Pacific Islander
  6. Non-Hispanic Black
  7. Non-Hispanic White
  8. White (includes Hispanic)
Sex
  1. Both Sexes
  2. Female
  3. Male
Stage at Diagnosis
  1. All Stages
  2. Distant
  3. Localized
  4. Regional
  5. Unstaged
Years of Diagnosis
  1. 2000-2021
id
pancreas
immutable id
seer-group:pancreas@a341038b6032f625ed58562f9e60ccd0d91f64e8d52942455de5748d686fe53f
method
Relative survival calculated using monthly intervals; table publishes annual landmarks from diagnosis through year ten.
missing value definition
Source dash (-) does not differentiate suppression, unavailable data, or other missingness. No suppression reason is inferred.
normalized source
period interpretation
The displayed diagnosis period is the source table label. Exact case-eligible years are not inferred from it.
registry
SEER 21 (excluding Illinois)
sheet
Pancreas
site
Pancreas
source
retrieved at
2026-09-09T23:23:39.141323+00:00
title
Survival by Survival Time
source footnotes
  1. row
    13208
    values
    1. Footnotes
  2. row
    13209
    values
    1. Data Source:
  3. row
    13210
    values
    1. -SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries [https://seer.cancer.gov/registries/terms.html] (excluding Illinois).
  4. row
    13211
    values
    1. -Expected Survival Life Tables [https://seer.cancer.gov/expsurvival/] by Socio-Economic Standards.
  5. row
    13212
    values
    1. Methodology:
  6. row
    13213
    values
    1. -The relative survival rates are calculated using monthly intervals.
  7. row
    13214
    values
    1. Race/Ethnicity Coding:
  8. row
    13215
    values
    1. -For more details on SEER race/ethnicity groupings, please see Race and Hispanic Ethnicity Changes [https://seer.cancer.gov/seerstat/variables/seer/race_ethnicity/].
  9. row
    13216
    values
    1. -Incidence data for Hispanics and Non-Hispanics are based on the NAACCR Hispanic Latino Identification Algorithm (NHIA).
  10. row
    13217
    values
    1. -Rates for American Indians/Alaska Natives only include cases that are in a Purchased/Referred Care Delivery Area (PRCDA).
  11. row
    13218
    values
    1. Cancer Site Coding:
  12. row
    13219
    values
    1. -See SEER*Explorer Cancer Site Definitions [https://seer.cancer.gov/statistics-network/explorer/cancer-sites.html] for details about the cancer site coding used for SEER Incidence data.
source header rows
    1. SEER Explorer Data Archive, November 2024 SEER Submission (April 2025 Release)
    1. Pancreas
    1. SEER Relative Survival Rates by Time Since Diagnosis
source missing marker
-
stage coding footnotes
  1. row
    13220
    values
    1. -Stage at diagnosis is calculated using the Combined Summary Stage (2004+) recode, created from SEER Combined Summary Stage 2000 (2004-2017) & Derived Summary Stage 2018 (2018+). For more information, see the SEER documentation[https://seer.cancer.gov/seerstat/variables/seer/lrd-stage].
stage period caveat
Combined Summary Stage (2004+) uses coding starting in 2004; the 2000-2021 label must not be read as full stage-specific coverage from 2000.
stage system
Combined Summary Stage (2004+)